PMID- 25131160 OWN - NLM STAT- MEDLINE DCOM- 20150724 LR - 20240510 IS - 1931-8405 (Electronic) IS - 0889-2229 (Print) IS - 0889-2229 (Linking) VI - 30 IP - 12 DP - 2014 Dec TI - The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS. PG - 1197-202 LID - 10.1089/AID.2014.0106 [doi] AB - The present study investigated the immunological pathogenesis of immune reconstitution inflammatory syndrome (IRIS) in acquired immunodeficiency syndrome (AIDS) patients undergoing highly active antiretroviral therapy (HAART). A total of 238 patients with AIDS who received initial HAART were included in this prospective cohort study. Blood samples were collected immediately, at baseline, at week 12, and at week 24 after initial HAART and at the onset of IRIS. Lymphocyte subsets, Th1 and Th2 cytokines, and interleukin (IL)-7 levels were measured by flow cytometry or ELISA. Among the 238 patients with AIDS who received HAART, 47 patients developed IRIS. The percentages of CD4(+) and CD8(+) naive, memory, and activated cells exhibited no significant differences between AIDS patients with and without IRIS 24 weeks after initial HAART. The percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells was lower in IRIS patients than in non-IRIS patients before HAART, 12 weeks after HAART, 24 weeks after HAART, and at the onset of IRIS. IL-2 and interferon (IFN)-gamma levels were significantly higher at week 4 and at the onset of IRIS in IRIS patients than in non-IRIS patients. In contrast, IL-4 and IL-10 levels were significantly lower at week 4 and at the onset of IRIS in IRIS patients than in non-IRIS patients. Plasma IL-7 decreased gradually with the progression of HAART. The level of IL-7 was higher in IRIS patients than in non-IRIS patients at all follow-up time points. An imbalance of Th1/Th2 cytokines, a consistently low CD(+)CD25(+)Fox3(+) percentage, and a high IL-7 level may be crucial in the pathogenesis of IRIS in AIDS patients who had received HAART. FAU - Zheng, Yuhuang AU - Zheng Y AD - AIDS Laboratory, Department of Infectious Diseases, Second Xiangya Hospital, Central-South University , Changsha, Hunan, People's Republic of China . FAU - Zhou, Huaying AU - Zhou H FAU - He, Yan AU - He Y FAU - Chen, Zi AU - Chen Z FAU - He, Bo AU - He B FAU - He, Mei AU - He M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - AIDS Res Hum Retroviruses JT - AIDS research and human retroviruses JID - 8709376 RN - 0 (Anti-HIV Agents) RN - 0 (Interleukin-2) RN - 0 (Interleukin-7) RN - 130068-27-8 (Interleukin-10) RN - 207137-56-2 (Interleukin-4) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Acquired Immunodeficiency Syndrome/*drug therapy MH - Adult MH - Anti-HIV Agents/administration & dosage/therapeutic use MH - Antiretroviral Therapy, Highly Active/*adverse effects MH - Female MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/epidemiology/*etiology MH - Interferon-gamma/blood MH - Interleukin-10/blood MH - Interleukin-2/blood MH - Interleukin-4/blood MH - Interleukin-7/blood MH - Male MH - Middle Aged MH - Prospective Studies MH - Risk Factors MH - T-Lymphocyte Subsets/drug effects MH - Time Factors PMC - PMC4250954 EDAT- 2014/08/19 06:00 MHDA- 2015/07/25 06:00 PMCR- 2015/12/01 CRDT- 2014/08/19 06:00 PHST- 2014/08/19 06:00 [entrez] PHST- 2014/08/19 06:00 [pubmed] PHST- 2015/07/25 06:00 [medline] PHST- 2015/12/01 00:00 [pmc-release] AID - 10.1089/aid.2014.0106 [pii] AID - 10.1089/AID.2014.0106 [doi] PST - ppublish SO - AIDS Res Hum Retroviruses. 2014 Dec;30(12):1197-202. doi: 10.1089/AID.2014.0106.